These approaches may help clarify whether the elevation of Gal1 and Gal9 reflects a general regulatory mechanism in IMIDs or supports their potential utility as diagnostic biomarkers, particularly in RA. This evidence concerns the gene LGALS9 and rheumatoid arthritis.